Literature DB >> 12801586

What we know and what we need to know about the role of endogenous CCK in psychostimulant sensitization.

Margery C Beinfeld1.   

Abstract

The unique distribution of CCK and its receptors and its co-localization with dopamine makes it ideally situated to pay a role in dopamine-mediated reward and psychostimulant sensitization. A number of studies support the hypothesis that CCK acting through the CCK 1 and CCK 2 receptors is an endogenous modulator of dopamine neurotransmission. Behavioral studies with CCK antagonists and CCK 1 receptor mutant rats support a role for endogenous CCK in behavioral sensitization to psychostimulants. CCK microdialysis studies in the nucleus accumbens (NAC) have demonstrated that extracellular CCK is increased in the NAC by psychostimulants, providing neurochemical evidence that CCK could be involved in the behavioral response to psychostimulants. A model for how CCK may be acting in multiple brain regions to foster sensitization is presented and the gaps in our knowledge about the role of CCK in psychostimulant sensitization are described.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801586     DOI: 10.1016/s0024-3205(03)00384-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats.

Authors:  S J Ballaz; J Perez; M Waselus; H Akil; S J Watson
Journal:  Neuroscience       Date:  2013-10-09       Impact factor: 3.590

Review 2.  Obesity and addiction: neurobiological overlaps.

Authors:  N D Volkow; G-J Wang; D Tomasi; R D Baler
Journal:  Obes Rev       Date:  2012-09-27       Impact factor: 9.213

3.  Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference.

Authors:  Klara Felszeghy; José Manuel Espinosa; Hélène Scarna; Anne Bérod; William Rostène; Didier Pélaprat
Journal:  Neuropsychopharmacology       Date:  2007-03-14       Impact factor: 7.853

4.  CSF cholecystokinin, gamma-aminobutyric acid and neuropeptide Y in pathological gamblers and healthy controls.

Authors:  C Nordin; I Sjödin
Journal:  J Neural Transm (Vienna)       Date:  2006-11-17       Impact factor: 3.575

5.  Altered dopamine D2 receptor function and binding in obese OLETF rat.

Authors:  Andras Hajnal; Wojciech M Margas; Mihai Covasa
Journal:  Brain Res Bull       Date:  2007-08-08       Impact factor: 4.077

6.  Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status.

Authors:  Elmira Anderzhanova; Mihai Covasa; Andras Hajnal
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-06       Impact factor: 3.619

7.  Dopamine D2 receptors contribute to increased avidity for sucrose in obese rats lacking CCK-1 receptors.

Authors:  A Hajnal; B C De Jonghe; M Covasa
Journal:  Neuroscience       Date:  2007-08-02       Impact factor: 3.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.